AOP-HEALTH
At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada) for its ultra-short-acting, cardioselective β1-blocker Landiolol. The drug is used in intensive care to treat atrial fibrillation and atrial flutter (supraventricular tachycardia) and non-compensatory sinus tachycardia, hence when the heartbeat accelerates acutely without an identifiable cause. The authorization allows a certain group of intensive care patients access to an additional therapy option. In addition, it opens the door to the North American market for AOP Health.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231213536304/en/
Martin Steinhart, CEO, AOP Health; Copyright: AOP Health/Studio Koekart
Landiolol, which is already authorized in the EU, has been repeatedly presented to the Canadian medical community at international medical congresses. In Canada, Landiolol will only be available in hospitals.
Martin Steinhart, CEO, AOP Health: "The approval of Landiolol in Canada is a great success for us because it shows that we have helped to expand the therapy options for intensive care patients through our research and development activities."
Local Distributor
Landiolol will be launched and distributed through a local partner, Trimedic Therapeutics Inc.
Csilla Repas, AOP Health Corporate Alliance Director explains: "As an established stakeholder in the Canadian healthcare sector and an expert in the field of intensive care medicine, Trimedic Therapeutics Inc. has the necessary know-how to successfully accompany the market entry. We are pleased that we have been able to acquire a strong partner in Trimedic Therapeutics Inc. for this important task."
About supraventricular tachycardia
Supraventricular tachycardia (including atrial fibrillation and atrial flutter) can occur in patients with and without heart disease alike. Since these conditions can impair cardiac function and thus lead to acute problems of the cardiovascular system, they require immediate medical attention. Compared to other β1-selective beta blockers, AOP Health's ultra-short-acting beta blockers are characterized by a faster onset of effect and a rapid reduction of the heart rate without significantly lowering the blood pressure. The use of this intravenously administered beta-blocker is limited to acute situations and emergencies and is not intended for the treatment of chronic cardiac arrhythmias.
About AOP Health
The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”). The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions operating from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. The claim “Needs. Science. Trust.” sums up the foundation of the Group’s success: establishing trust through a continually high level of investment in research and development and a highly consistent and pragmatic orientation towards the needs of all stakeholders – especially the patients and their families as well as the healthcare professionals treating them.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231213536304/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cognite Atlas AI™ Drives Customer Momentum with New Major Release, Accelerates Adoption of Agentic AI to Unlock More Industrial Value9.9.2025 21:00:00 CEST | Press release
Cognite Atlas AI is being leveraged by a wide range of customers globally, including Aker BP, ADNOC Offshore, Celanese, Hess Corporation, HMH, Idemitsu, and Tokuyama, and by partners such as SLB, Radix, Omny, Tridiagonal.ai, and ReVisionz. Cognite, the global leader in industrial AI, today announced a major release of Cognite Atlas AI™, the only low-code industrial AI agent workbench to power agents with real-time, AI-ready operational technology (OT), information technology (IT), and engineering data. This rapid momentum includes onboarding new customers weekly, a testament to its effectiveness in driving industrial digital transformation and value. The latest product release will be showcased at an oversubscribed Atlas AI Summit with hundreds of attendees in Tokyo, Japan, on September 10th. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909488860/en/ Cognite, the global leader in industrial AI, today announced a major r
Mouser Electronics Explores the 3D Printing Revolution and Its Impact on Design, Engineering, and Manufacturing9.9.2025 17:11:00 CEST | Press release
Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, today released its latest installment of the Empowering Innovation Together (EIT) technology series, entitled, That's 3D Printed? This installment explores how the foundational principles of 3D printing, also known as additive manufacturing, have advanced to transform design, engineering, and manufacturing through novel materials, artificial intelligence (AI), accelerated production cycles, and unparalleled design precision. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909696607/en/ Discover how additive manufacturing transforms design, accelerates production, and unlocks new possibilities...one layer at a time. The ingenuity of 3D printing lies in its ability to fabricate highly complex geometries and intricate internal structures, a feat often unachievable with conventional subtractive
Rimini Street Selected by 100+ Organizations as their Preferred Support Solution for VMware9.9.2025 15:00:00 CEST | Press release
Clients around the world are benefitting from the premium support, exclusive hypervisor security and extended life for perpetual licenses powered by Rimini Support™ for VMware Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, announces a new client milestone, surpassing 100 VMware contracts served to date. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909900104/en/ Rimini Street Selected by 100+ Organizations as their Preferred Support Solution for VMware Selected by the some of the world’s leading CIOs at global organizations as their preferred VMware support partner for perpetual licenses, Rimini Support™ for VMware continues to lead the market as a powerful, proven solution for protecting and maximizing the full value of VMware investments. By partnering
Regula Hits NIST Test: The Only Vendor Recognized Among Top Performers in All Critical Age Estimation Scenarios9.9.2025 14:30:00 CEST | Press release
For the first time, Regula, a global developer of identity verification (IDV) solutions and forensic devices, has taken part in the National Institute of Standards and Technology (NIST) evaluation for age estimation. This debut could hardly be stronger: Regula achieved the best result in the test, outperforming other vendors. Crucially, Regula’s technology demonstrated consistent accuracy across a wide range of demographics, making it the most universal solution on the market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909879354/en/ Regula’s technology estimates age with unmatched precision, gaining top results in the independent NIST test In addition, Regula ranked among the top three in two of the most critical age assurance scenarios: Challenge 25 and Child Online Safety (ages 13–16). NIST is a globally respected authority in technology testing and standardization. Its Face Analysis Technology Evaluation (FATE) Age
Other World Computing to Debut New Thunderbolt 5 Dual 10GbE Network Dock Alongside Its Industry-Leading Roster of Storage and Connectivity Solutions at IBC20259.9.2025 14:30:00 CEST | Press release
Attendees To See First-Hand How OWC Is Raising The Bar for Speed, Reliability, and Workflow Flexibility – Enabling Content Creators To Bring Ideas To Life, Without Compromise Other World Computing (OWC®), a trusted leader in high-performance storage, memory, connectivity, software, and accessories that empower creative and business professionals to maximize performance, enhance reliability, and streamline workflows, today announced it will debut its new OWC Thunderbolt 5 Dual 10GbE Network Dock, as well as showcase its unrivaled roster of storage and connectivity solutions, at IBC2025, taking place September 12-15 (RAI Amsterdam). Visitors to OWC’s Booth – Hall 7, Booth 7.A60 – will have the opportunity to see first-hand a wide range of OWC storage and connectivity innovations relied on by top creative and business professionals worldwide. New Product Debuts: - OWC Thunderbolt 5 Dual 10GbE Network Dock - This powerful dock enables users to connect to multiple high-speed networks, acces
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom